Showing results (121-130 of 239) with videos related to

Sort By:
Pageof 24
Zeitschrift Fur Rheumatologie|November 3, 2025
[Patient satisfaction in patients with rheumatoid arthritis : Effects of delegation to rheumatological specialist assistants]Birte Luise Hägermann, Juliana Rachel Hoeper, Sara Eileen Meyer, et al.
Circulation Research|May 8, 2010
Development of a drug screening platform based on engineered heart tissueArne Hansen, Alexandra Eder, Marlene Bönstrup, et al.
Circulation. Arrhythmia and Electrophysiology|June 22, 2018
Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic TriggersMarc D Lemoine, Tobias Krause, Jussi T Koivumäki, et al.
Scientific Reports|July 10, 2019
Human iPS cell-derived engineered heart tissue does not affect ventricular arrhythmias in a guinea pig cryo-injury modelSimon Pecha, Kaja Yorgan, Matti Röhl, et al.
Cell|December 5, 2002
Guidance of primordial germ cell migration by the chemokine SDF-1Maria Doitsidou, Michal Reichman-Fried, Jürg Stebler, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|March 4, 2009
Intestinal expression of TFF and related genes during postnatal development in a piglet probiotic trialJutta Scholven, David Taras, Soroush Sharbati, et al.
Cellular Signalling|March 7, 2021
Regulation of basal and norepinephrine-induced cAMP and ICa in hiPSC-cardiomyocytes: Effects of culture conditions and comparison to adult human atrial cardiomyocytesZafar Iqbal, Djemail Ismaili, Bernardo Dolce, et al.
Blood|October 28, 2004
Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune responseMarcus Odendahl, Henrik Mei, Bimba F Hoyer, et al.
Plos One|October 27, 2011
Human engineered heart tissue as a versatile tool in basic research and preclinical toxicologySebastian Schaaf, Aya Shibamiya, Marco Mewe, et al.
British Journal of Haematology|November 20, 2002
Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasiaJörg Hessling, Nicolaus Kröger, Mathias Werner, et al.
Pageof 24